ReviewClinical and experimental nephrology2026
Sedentary behavior as an emerging risk factor for chronic kidney disease: a narrative review.
Review in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictors of sedentary behaviour in adults: the role of social media addiction and physical activity - a cross-sectional study from Turkey.Journal of global health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Sedentary behavior (SB) has gained attention as one of the behavioral risk factors, independent of physical inactivity. Patients with chronic diseases, such as hypertension and type 2 diabetes, tend to have longer SB, and prolonged SB is reported as a risk factor for adverse outcomes. Recently, these concerns have also been increasingly recognized in patients with chronic kidney disease (CKD). Despite growing interest, the role of SB in this population is still not well understood. This review aims to summarize the existing evidence on the association between SB and the risk of CKD. A total of 17 studies (9 cross-sectional and 8 longitudinal) were reviewed, indicating that longer SB is associated with an increasing risk of CKD. Through this review, we suggest that reducing SB may play a role in preventing the onset and slowing the progression of CKD. However, evidence remains limited, such as regarding the effective approaches to reduce SB in daily life among patients with CKD, and the causality between CKD and SB. Further high-quality studies, including randomized controlled trials, are warranted to explore these issues in this population.
Indexed as
Identifiers
40938524What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.